ACLX Q3 2023 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M

Gross Profit

$15M97.0% margin

Operating Income

-$45M-299.9% margin

Net Income

-$39M-263.0% margin

EPS (Diluted)

$-0.81

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$18M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$614M

Total Liabilities

$348M

Stockholders' Equity

$266M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$0	—
Gross Profit	$15M	$0	—
Operating Income	-$45M	-$94M	+52.2%
Net Income	-$39M	-$93M	+57.6%